Concepedia

John C. Byrd

JC

116

Publications

16.3K

Citations

59

H-Index

1995

Active since

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Sarah Cannon

Cornell University

University of California San Diego

John C. Byrd is an author at The Ohio State University specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1995–2019

116

Publications

116

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Michael J. Keating, Ian W. Flinn, Vinay Jain et al. · Blood · 2002 · 946 citations · Full text

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

Laura Z. Rassenti, Lang Huynh, Tracy L. Toy et al. · New England Journal of Medicine · 2004 · 905 citations

Rows per page

1–5 of 116